DMS Blog

The Current Status of Alzheimer’s PET Imaging

The Current Status of Alzheimer’s PET Imaging

Alzheimer’s disease is the sixth leading cause of death in the United States. Around one in three American seniors die from Alzheimer’s or another dementia, making it a bigger killer than breast and prostate cancer combined. In fact, deaths from

Read More »
Pediatric PET Imaging: A 2020 Perspective

Pediatric PET Imaging: A 2020 Perspective

The world of pediatric imaging was revolutionized a couple of decades ago with the introduction of pediatric PET/CT. This subsequently found wide acceptance in pediatric oncological imaging, among other applications. PET/MRI is a more recent development, approved in pediatric patients

Read More »
The Clinical Impact of Utilizing NETSPOT

The Clinical Impact of Utilizing NETSPOT

NETSPOT (68Ga-Dotatate) is a radioactive diagnostic agent used for PET imaging that is gaining ground among practices. FDA-approved in 2016, NETSPOT is used in imaging to locate somatostatin receptor positive neuroendocrine tumors in adult and pediatric patients. The commercial product

Read More »
STAY IN THE KNOW

Sign-up to receive monthly imaging news and resources

CONNECT WITH DMS

©2020 DMS Health Technologies